Homo sapiens Protein: PEX10 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-86257.7 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | PEX10 | ||||||||||||||||||
Protein Name | peroxisomal biogenesis factor 10 | ||||||||||||||||||
Synonyms | NALD; PBD6A; PBD6B; RNF69; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000288774 | ||||||||||||||||||
InnateDB Gene | IDBG-86255 (PEX10) | ||||||||||||||||||
Protein Structure | |||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | Somewhat implicated in the biogenesis of peroxisomes. | ||||||||||||||||||
Subcellular Localization | Peroxisome membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}. | ||||||||||||||||||
Disease Associations | Peroxisome biogenesis disorder complementation group 7 (PBD-CG7) [MIM:614870]: A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS). {ECO:0000269PubMed:19105186}. Note=The disease is caused by mutations affecting the gene represented in this entry.Peroxisome biogenesis disorder 6A (PBD6A) [MIM:614870]: A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and clinically characterized by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life. {ECO:0000269PubMed:9700193}. Note=The disease is caused by mutations affecting the gene represented in this entry.Peroxisome biogenesis disorder 6B (PBD6B) [MIM:614871]: A peroxisome biogenesis disorder that includes neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD), two milder manifestations of the Zellweger disease spectrum. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy and vision impairment. Children with the NALD presentation may reach their teens, while patients with the IRD presentation may reach adulthood. The clinical conditions are often slowly progressive in particular with respect to loss of hearing and vision. The biochemical abnormalities include accumulation of phytanic acid, very long chain fatty acids (VLCFA), di- and trihydroxycholestanoic acid and pipecolic acid. {ECO:0000269PubMed:9683594}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||
Tissue Specificity | |||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 17 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR001841
Zinc finger, RING-type IPR006845 Pex, N-terminal IPR018957 Zinc finger, C3HC4 RING-type |
||||||||||||||||||
PFAM |
PF13639
PF14634 PF04757 PF00097 |
||||||||||||||||||
PRINTS | |||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART |
SM00184
|
||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | O60683 | ||||||||||||||||||
PhosphoSite | PhosphoSite-O60683 | ||||||||||||||||||
TrEMBL | J3QRM4 | ||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 5192 | ||||||||||||||||||
UniGene | Hs.732228 | ||||||||||||||||||
RefSeq | NP_722540 | ||||||||||||||||||
HUGO | HGNC:8851 | ||||||||||||||||||
OMIM | 602859 | ||||||||||||||||||
CCDS | CCDS41 | ||||||||||||||||||
HPRD | 04175 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AB013818 AF060502 AK124816 AL513477 BC000543 BC018198 CH471183 | ||||||||||||||||||
GenPept | AAC18133 AAH00543 AAH18198 BAA87895 BAG54100 CAI22603 EAW56105 EAW56107 EAW56108 | ||||||||||||||||||